Valsartan Dispersible Tablets 80mg

• Customization: Available
• Package: 7tablets/Box
• Composition: Valsartan Dispersible
• Model NO.: 80mg
• Transport Package: Free
• Specification: 80mg
• Trademark: Sinolead
• Origin: China

Product Description

Product	Dose	Package
Valsartan Dispersible Tablets	80mg	7Tablets/box

• Valsartan Dispersible Tablets represent a breakthrough in hypertension management, offering a convenient and easy-to-administer solution for individuals facing challenges with traditional tablet formulations.alsartan is a widely prescribed medication belonging to the class of angiotensin II receptor blockers (ARBs). It effectively lowers blood pressure by blocking the action of angiotensin II, a hormone that constricts blood vessels. This action helps relax blood vessels, allowing blood to flow more easily, thereby reducing blood pressure levels.

Indications:
 

• Hypertension (High Blood Pressure): Valsartan Dispersible Tablets are indicated for the treatment of hypertension in adults and children aged 6 to 18 years.
• Heart Failure: Valsartan may be used in adults to treat heart failure when standard therapy (e.g., ACE inhibitors) is not suitable or not tolerated.
• Post-Myocardial Infarction: Valsartan may be prescribed to improve survival following a heart attack in clinically stable patients with left ventricular failure or dysfunction.

Administration:
 

• Dosage: The dosage of Valsartan Dispersible Tablets varies depending on the patient's age, condition, and response to treatment. It is typically taken once daily, with or without food.
• Administration Instructions:
  • Dissolve the tablet in a glass of water or other suitable liquid.
  • Stir until the tablet is completely dissolved.
  • Drink the solution immediately after preparation.
  • Rinse the glass with more liquid and drink the rinse to ensure the entire dose is consumed.

 

Safety and Considerations:
 

• Contraindications:
  • Hypersensitivity to Valsartan or any component of the formulation.
  • History of angioedema related to previous treatment with ACE inhibitors or ARBs.
  • Pregnancy (second and third trimesters): Valsartan may cause fetal harm or death if used during pregnancy. Discontinue Valsartan as soon as pregnancy is detected.
• Warnings and Precautions:
  • Hypotension: Valsartan can cause symptomatic hypotension, especially in volume-depleted patients. Correct volume or salt depletion prior to initiation.
  • Renal Impairment: Monitor renal function periodically, particularly in patients with renal artery stenosis, severe heart failure, or those receiving concomitant diuretics.
  • Hyperkalemia: Valsartan may cause hyperkalemia, especially in patients with renal impairment or diabetes mellitus. Monitor serum potassium periodically.
• Adverse Reactions:
  • Common adverse reactions include dizziness, hypotension, hyperkalemia, and renal impairment.
  • Serious adverse reactions may include angioedema, renal dysfunction, and hepatotoxicity.